Through TCGA database analysis, we observed a negative correlation between high expression of FBXO43 and ImmuneScore (Fig. 6A), StromalScore (Fig. 6B) and ESTIMATEScore (Fig. 6C) in patients with HCC. This evidence concerns the gene FBXO43 and hepatocellular carcinoma.